Mitochondrial electron transport chain component (ETC component)

The mitochondrial electron transport chain component is any subunit of distinct multi-protein complexes (I–IV) or associated mobile carriers (ubiquinone, cytochrome c) in the inner mitochondrial membrane that transfers electrons from energy substrates (NADH, FADH2) to molecular oxygen. The flow of electrons drives proton pumping to establish a gradient used by ATP synthase to produce ATP, a process known as oxidative phosphorylation. These components are enzymes and transporter proteins fundamental to cellular energy production, apoptosis, redox signaling, and immune modulation. Dysfunction in individual ETC components is directly linked to numerous human diseases, including neurodegeneration, cancer, metabolic and cardiovascular disease, inflammation, and aging. A variety of small molecule drugs can modulate the function of one or more ETC components as therapeutic targets, but the complexity and ubiquity of mitochondrial bioenergetics create significant therapeutic challenges in specificity and safety.

Other names

Mitochondrial ETC proteinElectron transport chain complexRespiratory chain complexETC subunitComplex I–IVUbiquinonecytochrome c

Complex I inhibition (reduces reverse electron transfer and superoxide generation; e.g., metformin); Redox cycling (mild redox agents increase mitochondrial electron flow and reduce cell aging; e.g., methylene blue); Direct antioxidant effects (scavenge ROS, protect mitochondrial structures; e.g., CoQ10, MitoQ, NAC); Enhance mitochondrial biogenesis/mitophagy (e.g., rapamycin, Elamipretide); Direct ETC modulation/uncoupling (modulation of proton gradient, electron leak, etc.)